Cantor Fitzgerald Reiterates Overweight Rating on CVS Health Corporation (CVS)

Market Context

CVS Health Corporation operates in the Healthcare sector. The stock currently trades at $104.33 with a market capitalization of $102.6B. The stock has gained 32.8% over the past 52 weeks.

Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CVS Health Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for CVS Health Corporation

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 07, 2026	Cantor Fitzgerald	Overweight	N/A
Jun 23, 2026	B of A Securities	Buy	N/A
Jun 08, 2026	Mizuho	Outperform	N/A
Jun 04, 2026	Morgan Stanley	Overweight	N/A
Jun 01, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View CVS Stock Page